Patient Safety and Radiopharmaceuticals Administration: Minimizing Radiation Exposure and Risks
Worldwide Clinical Trials
JULY 8, 2024
Hormonal Status : A body’s hormones, such as levels of reproductive hormones and thyroid function, can impact tissue responses to radiation therapy. Similar to the FDA, the EMA evaluates radiopharmaceuticals for safety, efficacy, quality, and GMP regulation compliance before granting marketing authorization.
Let's personalize your content